BR

B-mono

n = 275

n = 100

Age, mean ± SD [median]

75.6 ± 6.5 [75.0]

75.4 ± 7.0 [74.0]

65 - 69 years, n (%)

42 (15.3)

18 (18.0)

70 - 74 years, n (%)

70 (25.5)

25 (25.0)

75 - 79 years, n (%)

73 (26.5)

27 (27.0)

≥80 years, n (%)

90 (32.7)

30 (30.0)

Male, n (%)

170 (61.8)

65 (65.0)

Region of residence, n (%)

South

89 (32.4)

40 (40.0)

North central

46 (16.7)

22 (22.0)

West

35 (12.7)

9 (9.0)

North east

69 (25.1)

23 (23.0)

Unknown

36 (13.1)

6 (6.0)

Year of index date, n (%)

2010

69 (25.1)

53 (53.0)

2011

63 (22.9)

20 (20.0)

2012

60 (21.8)

15 (15.0)

2013

56 (20.4)

10 (10.0)

2014

27 (9.8)

2 (2.0)

Months from first CLL diagnosis to index date, mean ± SD [median]

61.31 ± 42.02 [54.64]

61.78 ± 42.44 [60.58]

Charlson comorbidity index (CCI), mean ± SD [median]

3.53 ± 1.82 [3.00]

3.66 ± 1.87 [3.00]

Six most common physical and mental comorbidities

Hypertension

157 (57.1)

54 (54.0)

Lymphoma

134 (48.7)

53 (53.0)

Diabetes

81 (29.5)

27 (27.0)

Coagulopathy

79 (28.7)

26 (26.0)

Cardiac arrhythmias

68 (24.7)

21 (21.0)

Solid tumor

57 (20.7)

20 (20.0)